Some poorly differentiated tumors, such as colorectal cancer, ovarian cancer, and glioma, were found to have higher OY-TES-1 expression than well-differentiated tumors or their adjacent tissues [10, 11, 15]. Here, ACRBP is linked to colorectal cancer.